Hellmann J, Heuser I, Kronenberg G
Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charité-Universitätsklinikum Berlin, Campus Benjamin Franklin, Eschenallee 3, 14050, Berlin, Deutschland.
Nervenarzt. 2011 Jul;82(7):834-41. doi: 10.1007/s00115-010-3064-y.
Posttraumatic stress disorder (PTSD) is a severe, frequently chronic condition with a high rate of co-morbidity with other psychiatric syndromes. In contrast to the majority of psychiatric disorders, the traumatic event in PTSD constitutes a clearly defined etiological factor. A growing understanding of the mechanisms contributing to the development of PTSD has highlighted the possibilities for early preventive psychological and pharmacological treatment during the so-called golden hours after a traumatic experience. Whereas preliminary evidence suggests that a pharmacological recalibration of the HPA system and cognitive behavioral therapy may be helpful, other frequently used strategies, such as psychological debriefing or benzodiazepine treatment, seem to be largely ineffective, possibly even worsening PTSD symptoms.
创伤后应激障碍(PTSD)是一种严重且常为慢性的疾病,与其他精神综合征共病率很高。与大多数精神障碍不同,PTSD中的创伤事件构成了明确的病因因素。对导致PTSD发生机制的认识不断加深,凸显了在创伤经历后的所谓黄金时段进行早期预防性心理和药物治疗的可能性。虽然初步证据表明对下丘脑-垂体-肾上腺(HPA)系统进行药物重新校准以及认知行为疗法可能有帮助,但其他常用策略,如心理疏导或苯二氮䓬类药物治疗,似乎基本无效,甚至可能使PTSD症状恶化。